Author: Dr Henry Wei. Sources checked 18 October 2026.
Confirm iron deficiency and investigate the cause
I review haemoglobin, ferritin and their trends alongside symptoms, bleeding and inflammation. When ferritin is difficult to interpret, I add transferrin saturation. Ret-He may provide an additional clue to whether iron supply to developing red cells is restricted.
Treat confirmed deficiency while investigating blood loss or malabsorption. A response to iron supports the diagnosis but does not identify its cause.
1. Start with the clinical picture
Review the FBC, ferritin trend, symptoms and bleeding history. Check CRP and renal function when inflammation or kidney disease is possible. Recent iron treatment can affect the results.
Awanui Auckland’s lower ferritin reference limit for adults aged 20 and over is 30 µg/L, effective from 5 October 2026.
2. Read ferritin, TSAT and Ret-He together
With ferritin between 30 and 100 µg/L, low TSAT and Ret-He strengthen the evidence of iron restriction. Assess blood loss and inflammation to decide whether stores are depleted, iron is poorly available, or both.
| Marker | What it tells you | Practical interpretation |
|---|---|---|
| Ferritin | Iron stores, influenced by inflammation. | A value at or below 30 µg/L supports depleted stores, even with normal haemoglobin. Inflammation can raise ferritin and obscure deficiency. |
| TSAT | The proportion of transferrin carrying iron. | Below 20% supports restricted iron availability. This can occur with depleted stores or inflammatory iron restriction. |
| Ret-He | Recent iron supply to developing red cells. | A low result can help identify iron-restricted red-cell production when ferritin is equivocal. Interpret alongside ferritin, TSAT and the FBC. |
3. Look for the cause
Ask about menstrual and gastrointestinal blood loss, blood donation, diet, NSAIDs and previous gastrointestinal surgery. Check coeliac serology while the patient is eating gluten, and assess urinary blood loss when indicated.
Unexplained iron deficiency anaemia in an older individual usually warrants gastrointestinal assessment, often gastroscopy and colonoscopy. In menstruating patients, consider gastrointestinal investigation for concerning symptoms, recurrent anaemia, family risk or loss disproportionate to the menstrual history.
4. Replace iron and review the response
Start oral iron while investigating the cause. Once-daily dosing is usually sufficient; alternate-day dosing may improve tolerance. Consider intravenous iron for intolerance, inadequate response or impaired absorption.
Repeat the FBC after two to four weeks. If haemoglobin is not rising, check the dose actually taken, adherence, ongoing bleeding, absorption and other causes of anaemia. Document the repeat tests and investigation plan.
Clinical pearls
- Iron deficiency can be present before haemoglobin falls; a normal MCV does not exclude it.
- Ret-He can also be low in thalassaemia trait. Review unexplained microcytosis alongside the iron studies.
- In an anaemic patient taking daily oral iron, a haemoglobin rise of at least 10 g/L within two weeks strongly supports iron deficiency. Investigate the cause even when treatment works.
Related clinician articles
References
- bpacnz Bulletin 157: interpreting the new ASH iron guidance (2026)
- ASH 2026 guideline and implementation resources
- BSG iron deficiency anaemia guideline (2021)
- Health NZ Waikato laboratory: Ret-He
- AGA clinical update: iron deficiency anaemia management (2024)
- Awanui Labs Auckland: ferritin reference interval change, announced 2 October, effective 5 October 2026
